BPX-501 T cells: Clinical Trials

5 trials of BPX-501 T cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 2 terminated, 1 no longer available. 3 Phase 1, 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Active not recruiting 2, Terminated 1
Phase 23Terminated 2, Active not recruiting 1
Phase 31Terminated 1

Follow BPX-501 T cells: new trials by email Literature Review of BPX-501 T cells trials Research Report on BPX-501 T cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS
rivogenlecleucel, rimiducid, Cyclophosphamide - Acute Myeloid Leukemia, Myelodysplastic Syndromes
Phase 2 / Phase 3TerminatedBellicum Pharmaceuticals12018-12-272023-09-29
Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant
BPX-501 T cells, rimiducid - Hematologic Malignancy
Phase 1Active not recruitingBellicum Pharmaceuticals152018-02-012022-07-12
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
BPX-501 T cells, Rimiducid - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child
Phase 1 / Phase 2Active not recruitingBellicum Pharmaceuticals1202014-04-012022-07-12
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
BPX-501 T cells, Rimiducid - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child
Phase 1 / Phase 2TerminatedBellicum Pharmaceuticals1872014-04-012023-09-29
BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 Study
rivogenlecleucel, rimiducid - Hurler Syndrome, Inherited Metabolic Disorder
No longer availableBellicum Pharmaceuticals2020-10-05

Conditions studied

Myelodysplastic Syndromes (4)  ·  Hematologic Neoplasms (3)  ·  Leukemia (3)  ·  Leukemia, Myeloid, Acute (3)  ·  Anemia, Aplastic (2)  ·  Cytopenia (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Osteopetrosis (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Primary Immunodeficiency Diseases (2)  ·  Anemia (1)  ·  Anemia, Diamond-Blackfan (1)  ·  Anemia, Sickle Cell (1)  ·  Fanconi Anemia (1)  ·  Hemoglobinopathies (1)

Sponsors

Bellicum Pharmaceuticals (5)

Countries

United States (3)  ·  Italy (2)  ·  United Kingdom (1)